
Sangmi Cha
@sangmi_cha
Asia Stocks Reporter at Bloomberg(@business), ex-@Reuters. Born and raised in 🇰🇷🇺🇸🇧🇬🇷🇺 Schooled @UW, @SeoulNatlUni
ID: 948414572179812353
https://bloom.bg/3UJjl9a 03-01-2018 04:43:49
671 Tweet
1,1K Followers
533 Following

Chinese healthcare stocks are back in vogue after a $142 billion wipeout, as signs grow that the worst of a government crackdown is over bloomberg.com/news/articles/… via Bloomberg Markets


WuXi Biologics, one of China’s leading drug contract research and manufacturing companies, plunges as much as 25% before it was halted in Hong Kong trading after saying it expects conditions to remain “most challenging” through June bloomberg.com/news/articles/… via Bloomberg Markets


Asia’s top-performing fund managers are seeking opportunities in battered Chinese stocks and turning selective on the hot artificial intelligence theme as the region comes off a tough year bloomberg.com/news/articles/… via Bloomberg Markets

Want to follow Taiwan's election but don't know where to start? Read my colleague Cindy Wang's rundown of what's at stake when voters head to the polls on Saturday bloomberg.com/news/articles/…

Some of Hong Kong’s largest listed firms may step up purchases of their shares after buybacks rose to at least a six-year high in 2023 bloomberg.com/news/articles/… via Bloomberg Markets

China options data that look increasingly optimistic may actually be a sign that investors lack conviction in the market’s ability to stage a sustainable rally bloomberg.com/news/articles/… via Bloomberg Markets


WuXi AppTec tumbles by an intraday record in Hong Kong, with traders attributing the decline to proposed US legislation that would ban the Chinese medical technology company and its units from government contracts bloomberg.com/news/articles/… via Bloomberg Markets

Popular weight loss and diabetes drugs are getting caught up in a bid by US lawmakers to reduce the country’s reliance on Chinese biotech companies. From Sangmi Cha Michelle Fay Cortez + Madison Muller: bloomberg.com/news/articles/…

Traders have piled into options on WuXi Biologics to protect against potential swings with its sister company’s earnings in focus on Tuesday bloomberg.com/news/articles/… via Bloomberg Technology Sangmi Cha


South Korea is making weapons faster and cheaper than the US. Sangmi Cha steps inside an arms manufacturing facility and explains how the revival of one company could help the country’s weaponry ambitions trib.al/4cgE0gX

Traders are preparing for more swings ahead for shares of Chinese electric-car makers as governments around the world plan new tariffs via Sangmi Cha bloomberg.com/news/articles/… via Bloomberg Markets

After years of misery, brokers are scrambling to keep up with orders as Hong Kong and China stocks stage the world's biggest stock rally, writes Sangmi Cha. Meanwhile, Kristine Servando finds a waterfront seafood diner you don't want to miss in this week's Hong Kong Edition.



